Coastal Infusion Administers Xolair®

Xolair (omalizumab) is used as an add-on to existing asthma maintenance therapies when asthma symptoms are not adequately controlled with other medications. Xolair can also be used to treat chronic spontaneous urticaria.

The active substance in Xolair, omalizumab, is a monoclonal antibody, which is designed to attach to immunoglobulin E (IgE), a type of antibody in the blood. By attaching to IgE, omalizumab reduces free IgE in the blood. This means that when the body encounters an allergen, there is less IgE available to trigger an allergic reaction. This helps to reduce the symptoms of allergies, and reducing the amount of IgE shrinks nasal polyps and improves symptoms.

What It Treats

• Severe persistent asthma
• Chronic spontaneous urticaria (CSU)

Prescribed By

Xolair is most often prescribed by Pulmonologists, Allergists, and Immunologists.

How it’s Administered

Xolair is administered by subcutaneous injection. Xolair injections take only a few minutes.

Frequency

Xolair is generally administered once every four weeks.

Related Drugs

Cinqair, Dupixent, Fasenra, Nucala, Tezspire

Additional Resources

• Xolair Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies